[Impact of COVID-19 on dyslipidemia in Ecuador].
作者信息
Ferrés Font Mar, Salas Rosario
机构信息
Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, España.
Servicio de Medicina Interna, Hospital Universitari Sagrat Cor, Barcelona, España.
出版信息
Aten Primaria. 2025 May 30;57(10):103299. doi: 10.1016/j.aprim.2025.103299.
Abstract
摘要
相似文献
1
[Impact of COVID-19 on dyslipidemia in Ecuador].[新型冠状病毒肺炎对厄瓜多尔血脂异常的影响]
Aten Primaria. 2025 May 30;57(10):103299. doi: 10.1016/j.aprim.2025.103299.
2
Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022.2019冠状病毒病对厄瓜多尔血脂异常患病率的影响：一项2017年至2022年的横断面研究。
Aten Primaria. 2025 Apr;57(4):103007. doi: 10.1016/j.aprim.2024.103007. Epub 2024 Oct 18.
3
Excess deaths reveal the true spatial, temporal and demographic impact of COVID-19 on mortality in Ecuador.超额死亡揭示了 COVID-19 对厄瓜多尔死亡率的真实空间、时间和人口统计学影响。
Int J Epidemiol. 2022 Feb 18;51(1):54-62. doi: 10.1093/ije/dyab163.
4
Hyperglycemia and dyslipidemia of Isabela, Galápagos, Ecuador: A pilot study of cardiovascular risk factors in an Isolated Island community.厄瓜多尔加拉帕戈斯群岛伊莎贝拉岛的高血糖和血脂异常：一个孤立岛屿社区心血管危险因素的初步研究。
Diabetes Res Clin Pract. 2017 Aug;130:108-112. doi: 10.1016/j.diabres.2017.05.015. Epub 2017 May 26.
5
Case Fatality Rate of COVID-19 and its Relationship to Sociodemographic Characteristics in Ecuador, 2020.2020 年厄瓜多尔 COVID-19 病死率及其与社会人口特征的关系。
Int J Public Health. 2022 Sep 6;67:1604768. doi: 10.3389/ijph.2022.1604768. eCollection 2022.
6
Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.利用 2020 年 3 月 17 日至 10 月 22 日的超额死亡率初步估计来衡量厄瓜多尔 COVID-19 疫情的影响。
Int J Infect Dis. 2021 Mar;104:297-299. doi: 10.1016/j.ijid.2020.12.045. Epub 2020 Dec 19.
7
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors.通过对献血者血液中抗 SARS-CoV-2 IgG/IgM 抗体的血清阳性率分析来评估厄瓜多尔的 COVID-19 疫情进展。
Front Cell Infect Microbiol. 2024 Jun 21;14:1373450. doi: 10.3389/fcimb.2024.1373450. eCollection 2024.
8
Social Determinants as Mediators of the Emotional State of People With Type 2 Diabetes and/or Hypertension During the COVID-19 Pandemic in Ecuador and Spain.在厄瓜多尔和西班牙的2型糖尿病和/或高血压患者中，社会决定因素作为新冠疫情期间其情绪状态的中介因素
Health Expect. 2024 Dec;27(6):e70123. doi: 10.1111/hex.70123.
9
Excess deaths reveal the true spatial, temporal, and demographic impact of COVID-19 on mortality in Ecuador.超额死亡揭示了新冠疫情对厄瓜多尔死亡率的真实时空及人口统计学影响。
medRxiv. 2021 Mar 1:2021.02.25.21252481. doi: 10.1101/2021.02.25.21252481.
10
Analysis of Excess Mortality Data at Different Altitudes During the COVID-19 Outbreak in Ecuador.厄瓜多尔新冠疫情期间不同海拔地区超额死亡率数据分析
High Alt Med Biol. 2021 Dec;22(4):406-416. doi: 10.1089/ham.2021.0070.
本文引用的文献
1
Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022.2019冠状病毒病对厄瓜多尔血脂异常患病率的影响：一项2017年至2022年的横断面研究。
Aten Primaria. 2025 Apr;57(4):103007. doi: 10.1016/j.aprim.2024.103007. Epub 2024 Oct 18.
2
Ultra-Processed Foods and Human Health: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.超加工食品与人类健康：前瞻性队列研究的系统评价和荟萃分析。
Adv Nutr. 2024 Jan;15(1):100121. doi: 10.1016/j.advnut.2023.09.009. Epub 2023 Dec 18.
3
Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.2 型糖尿病代谢性血脂异常与心血管结局：来自 LOOK AHEAD 研究的结果。
J Am Heart Assoc. 2021 Apr 6;10(7):e016947. doi: 10.1161/JAHA.120.016947. Epub 2021 Mar 17.
Zotero 插件